| Colossolactone-G synergizes the anticancer properties of 5-fluorouracil and gemcitabine against colorectal cancer cells RA Algehani, R Abou Khouzam, GA Hegazy, AA Alamoudi, ... Biomedicine & Pharmacotherapy 140, 111730, 2021 | 11 | 2021 |
| The anterior gradient homologue 2 (AGR2) co-localises with the glucose-regulated protein 78 (GRP78) in cancer stem cells, and is critical for the survival and drug resistance … D Hussein, R Alsereihi, AAA Salwati, R Algehani, A Alhowity, AM Al-Hejin, ... Cancer cell international 22 (1), 387, 2022 | 6 | 2022 |
| A paediatric dysembryoplastic neuroepithelial tumour (DNET) with deregulated stem cell markers: a case report D Hussein, A Alhowity, R Algehani, AAA Salwati, A Dallol, HJ Schulten, ... Translational Pediatrics 11 (6), 1040, 2022 | 2 | 2022 |
| In-vitro combination analysis for colossolactone-G with gemcitabine and 5-fluoruracil against colorectal cancer cells RA Aljohani, RS Eldine, GA Hegazy, AA Alamoudi, GA Agabnoor, ... Cancer Research 79 (13_Supplement), 308-308, 2019 | | 2019 |
| Colossolactone-G enhances the anticancer properties of 5-fluorouracil and gemcitabine against colorectal cancer cells RA Aljohani, GA Hegazy, AA Alamoudi, AM El-Halawany, RS Eldine, ... Cancer Research 78 (13_Supplement), 5819-5819, 2018 | | 2018 |
